Carlyle Stock Slides 13% Over 7 Straight Down Days
A multi-day slide in the company’s stock has put its fundamental picture into sharper focus for investors.
A seven-day slide in Carlyle (CG) stock has erased about $2.3 billion from the company’s market value. The stock has now moved lower for 7 consecutive trading days, a cumulative loss of 13% that leaves its market capitalization at about $15 billion.
For anyone holding the stock, the move has been significantly steeper than the market’s. Carlyle stock trades at about $41.42 a share as of 9/15/2026.
CG Versus The S&P 500, Streak And Beyond
Here is how CG stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | CG | S&P 500 |
|---|---|---|
| 1D | -1.0% | -0.4% |
| 7D (Current Streak) | -13.3% | -2.1% |
| 1M (21D) | -15.3% | -2.6% |
| 3M (63D) | -9.8% | 0.4% |
| YTD 2026 | -28.4% | 10.8% |
| 2025 | 20.2% | 16.4% |
| 2024 | 28.1% | 23.3% |
| 2023 | 42.6% | 24.2% |
What does the data show about this selling pressure?
The recent decline is primarily specific to the stock, not a reflection of the broader market’s movement over the same period. While the S&P 500 returned -2.1% over the last 7 trading days, Carlyle fell by a much larger amount. The sources reviewed for this note do not show why the move happened.
Revenue over the last twelve months declined 25.2%, which compares to a median revenue growth of 10.2% among S&P 500 Financials stocks. This recent contraction follows a stronger period, as its 3-year average annual revenue growth is 23.6%.
A streak is information, not an instruction.
A streak of this length is a clear signal about momentum and where market attention is currently focused. It is not, by itself, a reason to buy or sell. The disciplined response is to treat the price change as a prompt to re-evaluate the business.
The numbers here provide a starting point for that work, setting a sharp price move against the company’s underlying performance.
If the drop has you weighing an entry, resist buying on price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still hold up.
Falling Prices Test Conviction. Rules Do Not Flinch
A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and decisions made that way tend to be expensive ones.
The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the rules decide, not the tape.